Pulnovo Medical is an innovative medical device company committed to enhancing the clinical value for patients in the field of pulmonary hypertension (PH) and heart failure. With a focus on breakthrough therapies, Pulnovo Medical strives to improve patients' resilience and quality of life. As a trailblazer in China's medical device industry, Pulnovo Medical leverages its extensive clinical resources and international perspective to explore cutting-edge technologies and develop innovative solutions at different stages of PH and heart failure.

The company aims to slow down and improve the progression of diseases, ultimately reshaping the landscape of the industry through technological innovation. Over the years, Pulnovo Medical has achieved significant milestones, including introducing the Pulmonary Artery Denervation (PADN) procedure, completing the construction of a state-of-the-art production base, obtaining patents in multiple countries, and receiving recognition and awards for its contributions to medical science. Driven by the vision of enhancing patients' life recovery power, Pulnovo Medical remains dedicated to providing breakthrough therapies driven by clinical value, ensuring that patients always have the support they need on their journey to recovery